Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jacob M van Laar"'
Autor:
Yves Luder, Mary Safy-Khan, Xavier M Teitsma, Johannes W. J. Bijlsma, Maria J.H. de Hair, Attila Pethoe-Schramm, Johannes W G Jacobs, Paco M J Welsing, Michael D Edwardes, Jacob M van Laar, Jenny Devenport
Publikováno v:
Annals of the Rheumatic Diseases. 79:460-463
BackgroundIn rheumatoid arthritis (RA) trials, inclusion of patients on background treatment with glucocorticoids (GCs) might impact efficacy and safety outcomes.ObjectivesTo determine if inclusion of patients on background GC use influenced efficacy
Autor:
Ulf Müller-Ladner, Klaus Warnatz, Nancy Agmon-Levin, F. C. Breedveld, Leo Smolar, Karen Schreiber, Ori Elkayam, Sander van Assen, Anna Molto, Marloes W Heijstek, Victoria Furer, Jacob M van Laar, Meliha C Kapetanovic, Christien Rondaan, Maxime Dougados, Nico M Wulffraat, Marc Bijl, Raffaele D'Amelio, James T. Walker, A. De Thurah, Robert Landewé
Publikováno v:
Annals of the rheumatic diseases, 79(1), 39-52. BMJ Publishing Group
Furer, V, Rondaan, C, Heijstek, M W, Agmon-Levin, N, Van Assen, S, Bijl, M, Breedveld, F C, D'amelio, R, Dougados, M, Kapetanovic, M C, Van Laar, J M, De Thurah, A, Landewé, R B M, Molto, A, Müller-Ladner, U, Schreiber, K, Smolar, L, Walker, J, Warnatz, K, Wulffraat, N M & Elkayam, O 2020, ' 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases ', Annals of the rheumatic diseases, vol. 79, no. 1, pp. 39-52 . https://doi.org/10.1136/annrheumdis-2019-215882
Furer, V, Rondaan, C, Heijstek, M W, Agmon-Levin, N, Van Assen, S, Bijl, M, Breedveld, F C, D'amelio, R, Dougados, M, Kapetanovic, M C, Van Laar, J M, De Thurah, A, Landewé, R B M, Molto, A, Müller-Ladner, U, Schreiber, K, Smolar, L, Walker, J, Warnatz, K, Wulffraat, N M & Elkayam, O 2020, ' 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases ', Annals of the Rheumatic Diseases, vol. 79, no. 1, pp. 39-52 . https://doi.org/10.1136/annrheumdis-2019-215882
Furer, V, Rondaan, C, Heijstek, M W, Agmon-Levin, N, Van Assen, S, Bijl, M, Breedveld, F C, D'amelio, R, Dougados, M, Kapetanovic, M C, Van Laar, J M, De Thurah, A, Landewé, R B M, Molto, A, Müller-Ladner, U, Schreiber, K, Smolar, L, Walker, J, Warnatz, K, Wulffraat, N M & Elkayam, O 2020, ' 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases ', Annals of the rheumatic diseases, vol. 79, no. 1, pp. 39-52 . https://doi.org/10.1136/annrheumdis-2019-215882
Furer, V, Rondaan, C, Heijstek, M W, Agmon-Levin, N, Van Assen, S, Bijl, M, Breedveld, F C, D'amelio, R, Dougados, M, Kapetanovic, M C, Van Laar, J M, De Thurah, A, Landewé, R B M, Molto, A, Müller-Ladner, U, Schreiber, K, Smolar, L, Walker, J, Warnatz, K, Wulffraat, N M & Elkayam, O 2020, ' 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases ', Annals of the Rheumatic Diseases, vol. 79, no. 1, pp. 39-52 . https://doi.org/10.1136/annrheumdis-2019-215882
To update the European League Against Rheumatism (EULAR) recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) published in 2011. Four systematic literature reviews were performed regarding the inci
Autor:
Michelle E A Borm, Suzanne P. Linn-Rasker, Marjolein J.H. de Hair, Johannes W G Jacobs, Floris P J G Lafeber, Attila Pethoe-Schramm, Jacob M van Laar, Xavier M Teitsma, Paco M J Welsing, Janneke Tekstra, Johannes W. J. Bijlsma, Maxime Verhoeven, Evert Jan ter Borg
Publikováno v:
Annals of the Rheumatic Diseases. 78:1333-1338
Objectives Methotrexate (MTX), often combined with low moderately dosed prednisone, is still the cornerstone of initial treatment for early rheumatoid arthritis (RA). It is not known how this strategy compares with initial treatment with a biological
Autor:
Ulf Müller-Ladner, Tracy M. Frech, Murray Baron, Jeffrey Siegel, Daniel E. Furst, Angelika Jahreis, Yannick Allanore, Laura Burke, Gerhard Fierlbeck, Christopher P. Denton, Dinesh Khanna, Janet E. Pope, Helen Spotswood, Gabriela Riemekasten, Virginia D. Steen, Lorinda Chung, Marina E Anderson, Santhanam Lakshminarayanan, Celia J. F. Lin, Jacob M van Laar
Publikováno v:
Annals of the Rheumatic Diseases
ANNALS OF THE RHEUMATIC DISEASES
ANNALS OF THE RHEUMATIC DISEASES
ObjectivesAssess the efficacy and safety of tocilizumab in patients with systemic sclerosis (SSc) in a phase II study.MethodsPatients with SSc were treated for 48 weeks in an open-label extension phase of the faSScinate study with weekly 162 mg subcu
Autor:
Maxime Ma, Verhoeven, Marjolein Jh, de Hair, Janneke, Tekstra, Johannes Wj, Bijlsma, Jacob M, van Laar, Attila, Pethoe-Schramm, Michelle Ea, Borm, Evert-Jan, Ter Borg, Suzanne P, Linn-Rasker, Xavier M, Teitsma, Floris Pjg, Lafeber, Johannes Wg, Jacobs, Paco Mj, Welsing
Publikováno v:
Annals of the rheumatic diseases. 78(10)
Methotrexate (MTX), often combined with low moderately dosed prednisone, is still the cornerstone of initial treatment for early rheumatoid arthritis (RA). It is not known how this strategy compares with initial treatment with a biological. We theref
Autor:
Michelle E A Borm, Xavier M Teitsma, Johannes W G Jacobs, Johanna M. W. Hazes, Angelique E. A. M. Weel, Floris P J G Lafeber, Attila Pethö-Schramm, Jacob M van Laar, Paco M J Welsing, Johannes W. J. Bijlsma, Pascal H P de Jong
Publikováno v:
Annals of the Rheumatic Diseases, 78(1), 142-144. BMJ Publishing Group
Recently, we identified baseline higher disease activity score assessing 28 joints, current smoking and no alcohol consumption as predictors of inadequate response (IR) to methotrexate (MTX), used with or without other conventional synthetic disease
Autor:
Iain B. McInnes, Wolfgang Hueber, Juergen Braun, Kath Radford, Francois Vandenhende, Dominique Baeten, Jacob M van Laar, Herbert Kellner, Joachim Sieper, Xenofon Baraliakos, Babul Borah, Didier Laurent, Laurence Colin, Paul Emery, Paul Wordsworth, Juergen Wollenhaupt
Publikováno v:
Annals of the Rheumatic Diseases. 75:408-412
Introduction A 28-week study suggested efficacy of the anti-interleukin-17A monoclonal antibody secukinumab in active ankylosing spondylitis (AS). MRI-assessed inflammation was reduced at weeks 6, 28. Objective To analyse the longer-term effects of s
Autor:
Maureen D. Mayes, Gabriela Riemekasten, Alexandre E. Voskuyl, V. Fonollosa, Jane Worthington, Madelon C. Vonk, Miguel A. González-Gay, Christopher P. Denton, José Luis Callejas-Rubio, Alexander Kreuter, Javier Martin, F. David Carmona, Annemie J. Schuerwegh, Jasper C A Broen, Patricia Carreira, Rajan Madhok, Timothy R D J Radstake, Paul G. Shiels, Lina-Marcela Diaz-Gallo, Frank C. Arnett, Jörg H W Distler, Carmen P. Simeon, Nicolas Hunzelmann, Jacob M van Laar, Torsten Witte, Filemon K. Tan, M. Carmen Cénit, Carmen Fonseca, Shervin Assassi, Ariane L. Herrick, Francisco Javier López-Longo
Publikováno v:
Carmona, F D, Cenit, M C, Diaz-Gallo, L M, Broen, J C A, Simeon, C P, Carreira, P E, Callejas-Rubio, J L, Fonollosa, V, Lopez-Longo, F J, Gonzalez-Gay, M A, Hunzelmann, N, Riemekasten, G, Witte, T, Kreuter, A, Distler, J H W, Madhok, R, Shiels, P, van Laar, J M, Schuerwegh, A J, Vonk, M C, Voskuyl, A E, Fonseca, C, Denton, C P, Herrick, A, Worthington, J, Arnett, F C, Tan, F K, Assassi, S, Radstake, T R D J, Mayes, M D & Martin, J 2013, ' New insight on the Xq28 association with systemic sclerosis ', Annals of the Rheumatic Diseases, vol. 72, no. 12, pp. 2032-2038 . https://doi.org/10.1136/annrheumdis-2012-202742
Annals of the Rheumatic Diseases, 72, 12, pp. 2032-8
Annals of the Rheumatic Diseases, 72(12), 2032-2038. BMJ Publishing Group
Annals of the Rheumatic Diseases, 72, 2032-8
Annals of the Rheumatic Diseases, 72, 12, pp. 2032-8
Annals of the Rheumatic Diseases, 72(12), 2032-2038. BMJ Publishing Group
Annals of the Rheumatic Diseases, 72, 2032-8
ObjectiveTo evaluate whether the systemic sclerosis (SSc)-associated IRAK1 non-synonymous single-nucleotide polymorphism rs1059702 is responsible for the Xq28 association with SSc or whether there are other independent signals in the nearby methyl-Cp
Autor:
David F. Choy, Jason A. Hackney, Jacob M van Laar, Y K Onno Teng, Sarah K. Kummerfeld, Vanessa Hogan, Michael J. Townsend, Cecile T.J. Holweg
Publikováno v:
Annals of the Rheumatic Diseases. 71:1888-1894
ObjectivePersonalised healthcare is contingent on the identification of biomarkers that represent disease relevant pathways and predict drug response. The authors aimed to develop a gene expression signature in synovial tissue that could enrich clini
Publikováno v:
Annals of the Rheumatic Diseases. 68:1011-1016
To investigate the clinical effects of rituximab treatment in relation to immunological effects of rituximab on tissue-derived B lineage cells and repopulation of circulating B cells.A total of 24 patients with rheumatoid arthritis (RA) were treated